Latest Advances in Dermatology: From Molecular Insights into Clinical Applications

Dear Colleagues,

Precise diagnostic techniques and targeted therapies are the cornerstones of personalized medicine. In recent decades, substantial progress has been made in elucidating the molecular pathogenic mechanisms underlying numerous skin disorders, including inflammatory dermatoses and skin cancers.

The advent of innovative treatments, such as immunotherapy, biologic drugs targeting key cytokines in the pathophysiology of multiple inflammatory dermatoses, and JAK (tyrosine kinases inhibitors), has significantly revolutionized dermatology, improving the prognosis and management of previously challenging conditions, such as psoriasis, atopic dermatitis, alopecia areata, and metastatic melanoma.

Moreover, ongoing efforts to identify new biomarkers hold promise for predicting response and tolerability to specific therapies, thus minimizing side effects, improving the selection of patients eligible for therapies, and avoiding unnecessary treatments.

This Special Issue of Life invites original research articles, brief reports, and review articles that explore the latest advancements in the molecular diagnosis and targeted therapies of skin diseases. We aim to highlight cutting-edge research that bridges molecular insights and clinical applications, offering novel perspectives and therapeutic approaches to improve patient outcomes.

Dr. Emilio García Mouronte
Dr. Alfonso Perez-Gonzalez
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.